It looks like your are using Internet Explorer.

Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.

To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

19th July @ 10:45AM EDT

How can we leverage technological advancements to drive an explosive evolution in pathology? 

Digital pathology has shown many advantages such as improved sample analysis, fewer errors, reduced long-term costs, and better diagnostic results in less time, which ultimately leads to better patient outcomes. Many investors and pharma companies have realized the potential of digital pathology technologies in oncology, as well as the use of real-world evidence (RWE) and data (RWD). Join this masterclass led by Bill Taranto, President of the Merck Global Health Innovation Fund, to discuss and learn more about:

  • How technological advancements will drive an explosive evolution in pathology due to slide scanning, cloud computing/data storage, and Artificial Intelligence (AI). 
  • Where to invest? What do investors think about digital pathology? What gaps can it fill within pharma (in discovery, diagnostic, commercial, etc.)?
  • How RWD and RWE are the new Digital “DNA”, a composite of real-world data quality and volume, network scale & diversity, and digital health services, predicts the ability to execute valuable business use cases.
  • What are the things investors look at when investing in RWD solutions?

Apply to Attend

Thank you! Your submission has been received.

An invite invite link has been sent to you if you do not already have a HealthXL account.
Oops! Something went wrong while submitting the form.

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

Bill Taranto
President, Merck Global Health Innovation Fund
Jin Lee, Ph.D
Director of Digital Health, Astellas Pharma
Apply to Attend

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

No items found.

Join this HealthXL Event today:

Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.


You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.

19th July @ 10:45AM EDT

How can we leverage technological advancements to drive an explosive evolution in pathology? 

Digital pathology has shown many advantages such as improved sample analysis, fewer errors, reduced long-term costs, and better diagnostic results in less time, which ultimately leads to better patient outcomes. Many investors and pharma companies have realized the potential of digital pathology technologies in oncology, as well as the use of real-world evidence (RWE) and data (RWD). Join this masterclass led by Bill Taranto, President of the Merck Global Health Innovation Fund, to discuss and learn more about:

  • How technological advancements will drive an explosive evolution in pathology due to slide scanning, cloud computing/data storage, and Artificial Intelligence (AI). 
  • Where to invest? What do investors think about digital pathology? What gaps can it fill within pharma (in discovery, diagnostic, commercial, etc.)?
  • How RWD and RWE are the new Digital “DNA”, a composite of real-world data quality and volume, network scale & diversity, and digital health services, predicts the ability to execute valuable business use cases.
  • What are the things investors look at when investing in RWD solutions?

Apply to AttendRegister to AttendApply to Attend

Participants

Participants

Bill Taranto

President, Merck Global Health Innovation Fund

Jin Lee, Ph.D

Director of Digital Health, Astellas Pharma

Sheila Woodhouse

Senior Director, Digital Health Lead, Global Drug Development, Bristol Myers Squibb

Chris Cera

CEO, Arcweb Technologies

Uma Makhija Verma

Senior Director, Business Development, Biogen

Zina Manji

Sr Director of Regulatory Affairs at GSK

Tracy Lahey

Strategy & Business Development, Digital Health & Innovation at Amgen

Daniel Hach

COO of BI X - the digital lab of Boehringer Ingelheim

Hassan Naqvi

Lead, External Alliances and Digital Partnerships at AstraZeneca

Jeremy Sohn

Managing General Partner, P74 Ventures

Ary Deleray

Personalized & Digital Health Strategy at Roche

Jeff Wandzura

CEO, KEEP Labs

Alba Zurriaga Carda, PhD

Director of Digital Investments, Sanofi Ventures

Number of Participants


Up to 12
Date  
July 19, 2022
Community

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

How can we leverage technological advancements to drive an explosive evolution in pathology? 

Digital pathology has shown many advantages such as improved sample analysis, fewer errors, reduced long-term costs, and better diagnostic results in less time, which ultimately leads to better patient outcomes. Many investors and pharma companies have realized the potential of digital pathology technologies in oncology, as well as the use of real-world evidence (RWE) and data (RWD). Join this masterclass led by Bill Taranto, President of the Merck Global Health Innovation Fund, to discuss and learn more about:

  • How technological advancements will drive an explosive evolution in pathology due to slide scanning, cloud computing/data storage, and Artificial Intelligence (AI). 
  • Where to invest? What do investors think about digital pathology? What gaps can it fill within pharma (in discovery, diagnostic, commercial, etc.)?
  • How RWD and RWE are the new Digital “DNA”, a composite of real-world data quality and volume, network scale & diversity, and digital health services, predicts the ability to execute valuable business use cases.
  • What are the things investors look at when investing in RWD solutions?

Participate in the Meeting

HealthXL Roundtables

HealthXL community meetings connect senior leaders from around the world.

Our virtual Roundtables are small, participant-led discussions where the HealthXL community discuss digital health challenges and offer solutions.

Participant-Led

HealthXL community members lead discussion on a defined topic among a maximum of 12 participants. There is no audience and no recordings, just an interactive space to reflect and share learnings.

Developed for a Busy Schedule

At 60-minutes long, roundtables are long enough for meaningful discussion among peers, but short enough to fit into busy schedules.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports

HealthXL Masterclasses

HealthXL community events give unparalleled access to digital health leaders from around the world.

Our virtual Masterclasses are 60-minute sessions where a recognised expert in their field provides an in-depth learning experience to a small audience of 8-12 members.

EXPERT-Led

HealthXL Masterclasses give you a chance to join a small group of peers and ask questions of recognised experts in a private, convenient setting.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports

HealthXL Webinars

HealthXL community events give unparalleled access to digital health experts from around the world.

Our webinars bring together panels of 3-4 global leaders from the HealthXL community to discuss core trends in digital health.

Expert Panel Discussion

Gain insights on the latest topics in digital health and ask questions of the expert panel via chat. Webinars run for 60 minutes and recordings are shared with all attendees afterwards.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports
Virtual Digital Health Meeting

Join from anywhere

No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.

Apply to Attend now

The world of Digital Health in one Hub

Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers. 

As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.

Our community is growing fast. Don’t miss out on your opportunity to lead the future.


Join the community here
Reports & Insights
Reports and insights shared by the DTx community
Curated
News
Daily DTx News Curated by our in-house experts
Lists & Dashboards
Interactive dashboards and downloadable organisation data

Your Digital Health Corner

All Posts
Commentary
February 16, 2024
Tess’ Top Takes from this Month’s Meetings in Digital Health: February 2024
Tess’ Top Takes from this Month’s Meetings in Digital Health: February 2024
Read More
Commentary
February 9, 2024
Is There a Space for Digital Health in the World of RNA Based Therapeutics?
Is There a Space for Digital Health in the World of RNA Based Therapeutics?
Read More
Commentary
February 2, 2024
AI in Clinical Trials: Navigating the Trial-and-Error Process
AI in Clinical Trials: Navigating the Trial-and-Error Process
Read More

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

19th July @ 10:45AM EDT
Digital Health in Oncology

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

19th July @ 10:45AM EDT
Digital Health in Oncology
Bill Taranto
President, Merck Global Health Innovation Fund
LinkedIn Profile
Jin Lee, Ph.D
Director of Digital Health, Astellas Pharma
LinkedIn Profile
Sheila Woodhouse
Senior Director, Digital Health Lead, Global Drug Development, Bristol Myers Squibb
LinkedIn Profile
Chris Cera
CEO, Arcweb Technologies
LinkedIn Profile
Uma Makhija Verma
Senior Director, Business Development, Biogen
LinkedIn Profile
Zina Manji
Sr Director of Regulatory Affairs at GSK
LinkedIn Profile
Tracy Lahey
Strategy & Business Development, Digital Health & Innovation at Amgen
LinkedIn Profile
Daniel Hach
COO of BI X - the digital lab of Boehringer Ingelheim
LinkedIn Profile
Hassan Naqvi
Lead, External Alliances and Digital Partnerships at AstraZeneca
LinkedIn Profile
Jeremy Sohn
Managing General Partner, P74 Ventures
LinkedIn Profile
Ary Deleray
Personalized & Digital Health Strategy at Roche
LinkedIn Profile
Jeff Wandzura
CEO, KEEP Labs
LinkedIn Profile
Alba Zurriaga Carda, PhD
Director of Digital Investments, Sanofi Ventures
LinkedIn Profile

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

How can we leverage technological advancements to drive an explosive evolution in pathology? 

Digital pathology has shown many advantages such as improved sample analysis, fewer errors, reduced long-term costs, and better diagnostic results in less time, which ultimately leads to better patient outcomes. Many investors and pharma companies have realized the potential of digital pathology technologies in oncology, as well as the use of real-world evidence (RWE) and data (RWD). Join this masterclass led by Bill Taranto, President of the Merck Global Health Innovation Fund, to discuss and learn more about:

  • How technological advancements will drive an explosive evolution in pathology due to slide scanning, cloud computing/data storage, and Artificial Intelligence (AI). 
  • Where to invest? What do investors think about digital pathology? What gaps can it fill within pharma (in discovery, diagnostic, commercial, etc.)?
  • How RWD and RWE are the new Digital “DNA”, a composite of real-world data quality and volume, network scale & diversity, and digital health services, predicts the ability to execute valuable business use cases.
  • What are the things investors look at when investing in RWD solutions?

When:
19th July @ 10:45AM EDT
Apply to attend
Registration Closed

Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.

All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.

Frequently asked questions: 

What are HealthXL Virtual Meetings?

HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

How can I connect with other digital health leaders?

HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.

What are the benefits of being a HealthXL community member?

As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.

Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.